384 related articles for article (PubMed ID: 28063151)
1. GAD65 neurological autoimmunity.
McKeon A; Tracy JA
Muscle Nerve; 2017 Jul; 56(1):15-27. PubMed ID: 28063151
[TBL] [Abstract][Full Text] [Related]
2. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
3. [Stiff-person syndrome and related autoantibodies].
Tomioka R; Tanaka K
Brain Nerve; 2013 Apr; 65(4):395-400. PubMed ID: 23568987
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
Martinez-Hernandez E; Ariño H; McKeon A; Iizuka T; Titulaer MJ; Simabukuro MM; Lancaster E; Petit-Pedrol M; Planagumà J; Blanco Y; Harvey RJ; Saiz A; Graus F; Dalmau J
JAMA Neurol; 2016 Jun; 73(6):714-20. PubMed ID: 27065452
[TBL] [Abstract][Full Text] [Related]
6. Stiff-man syndrome and variants: clinical course, treatments, and outcomes.
McKeon A; Robinson MT; McEvoy KM; Matsumoto JY; Lennon VA; Ahlskog JE; Pittock SJ
Arch Neurol; 2012 Feb; 69(2):230-8. PubMed ID: 22332190
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
8. Familial autoimmunity in neurological patients with GAD65 antibodies: an interview-based study.
Muñiz-Castrillo S; Vogrig A; Montagnac C; Joubert B; Benaiteau M; Casez O; Chaumont H; Hopes L; Lanoiselée HM; Navarro V; Thomas B; Ursu R; Gonçalves D; Fabien N; Ducray F; Julier C; Honnorat J
J Neurol; 2021 Jul; 268(7):2515-2522. PubMed ID: 33544221
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.
Gresa-Arribas N; Ariño H; Martínez-Hernández E; Petit-Pedrol M; Sabater L; Saiz A; Dalmau J; Graus F
PLoS One; 2015; 10(3):e0121364. PubMed ID: 25774787
[TBL] [Abstract][Full Text] [Related]
10. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
11. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
[TBL] [Abstract][Full Text] [Related]
12. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
Walikonis JE; Lennon VA
Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
[TBL] [Abstract][Full Text] [Related]
14. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in a case of low titre GAD65 antibody-associated spectrum neurological disorders.
Wei M; Bannout F; Dastjerdi M; Phan C; Batarseh S; Guo X; Baker N
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38871638
[TBL] [Abstract][Full Text] [Related]
16. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome.
Burbelo PD; Groot S; Dalakas MC; Iadarola MJ
Biochem Biophys Res Commun; 2008 Feb; 366(1):1-7. PubMed ID: 18047830
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.
Ariño H; Gresa-Arribas N; Blanco Y; Martínez-Hernández E; Sabater L; Petit-Pedrol M; Rouco I; Bataller L; Dalmau JO; Saiz A; Graus F
JAMA Neurol; 2014 Aug; 71(8):1009-16. PubMed ID: 24934144
[TBL] [Abstract][Full Text] [Related]
18. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
19. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
Liimatainen S; Honnorat J; Pittock SJ; McKeon A; Manto M; Radtke JR; ; Hampe CS
Orphanet J Rare Dis; 2018 Apr; 13(1):55. PubMed ID: 29636076
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells.
Burton AR; Baquet Z; Eisenbarth GS; Tisch R; Smeyne R; Workman CJ; Vignali DA
J Immunol; 2010 May; 184(9):4863-70. PubMed ID: 20348424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
